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In this issue of Immunity, Ghisletti et al. (2010) examined lipopolysaccharide (LPS)-induced binding of the
p300 transcription coactivator to identify inducible enhancers throughout the genome of mouse macro-
phages, thereby revealing common features of enhancers that contribute to the LPS response and a critical
role for PU.1 in enhancer marking.Publication of the first human genome
sequences at the beginning of the 21st
century served as the catalyst for radical
changes in the experimental and com-
putational strategies used to advance
most biological disciplines, including
immunology and gene regulation. The
availability of whole-genome sequences
made it possible to identify and charac-
terize previously unknown genes, explore
genetic variation, better understand evo-
lution, and study the regulation of large
sets of coordinately expressed genes
rather than individual model genes. Exist-
ing technologies were refined to take
advantage of the genome sequences,
and new technologies rapidly emerged.
For genome-wide studies of transcrip-
tional regulation, key technologies
included microarray analysis of mRNAs,
chromatin immunoprecipitation (ChIP)
coupled to microarrays to monitor his-
tone modifications, nucleosome dynam-
ics, and transcription factor binding,
genome-wide nuclease hypersensitivity
methods, and chromatin conformation
capture-based techniques for evaluat-
ing the physical proximity of genomic
regions.
One of the newest techniques, ChIP-
seq, couples ChIP with massively parallel
sequencing (Barski et al., 2007). In brief,
nucleosomes, transcription factors, and
other chromatin-associated proteins are
covalently crosslinked to genomic DNA
in living cells; crosslinking is followed by
genome fragmentation and immunopre-
cipitation with an antibody targeted to
a protein or modified protein of interest.
After reversal of the crosslinking, the
genomic DNA in the immunoprecipitation
pellet is further fragmented and analyzed
by massively parallel sequencing. The
short reads are then computationally
aligned on the genome, revealing the296 Immunity 32, March 26, 2010 ª2010 Elsegenomic regions associated with the
protein (or modified histone) in the living
cells used for the experiment. In com-
parison to the ChIP-chip technique,
which relies on microarrays to evaluate
the immunoprecipitated DNA, ChIP-seq
appears to be much more sensitive and
quantitative.
In this issue of Immunity, Ghisletti et al.
(2010) examined whether ChIP-seq
could be used to identify, throughout the
genome, enhancers that contribute to
transcriptional activation in mouse mac-
rophages stimulatedwith lipopolysaccha-
ride ([LPS] endotoxin). This question is of
considerable importance because LPS
and other microbial and environmental
stimuli promote the induction of large
sets of genes that regulate inflammation
and both innate and adaptive immunity
(Medzhitov and Horng, 2009; Smale,
2010). Elucidation of the molecular mech-
anisms used to regulate inducible genes
will facilitate efforts to enhance antimicro-
bial immune responses while suppress-
ing aberrant responses associated with
disease.
Most studies of inducible gene tran-
scription in macrophages have focused
on promoters, which are easy to identify
because they coincide with transcription
start sites. Although promoters are
often sufficient for inducible transcription
in transient transfection assays (i.e.,
promoter-reporter assays), they are insuf-
ficient for active transcription in a native
chromosomal context (Carey et al., 2009).
To promote transcription in this context,
all genes are thought to contain one or
more enhancers, which can be located
dozens of kilobase pairs upstream or
downstream of the gene, or within the
gene’s introns. A typical enhancer spans
100–500 bps and contains binding sites
for multiple transcription factors. Physicalvier Inc.interactions between enhancer-associ-
ated proteins and promoter-associated
proteins, via DNA looping, are thought to
be responsible for transcriptional activa-
tion of an endogenous gene. However,
much remains to be learned about the
mechanisms of enhancer function.
Historically, enhancers have been
identified either by searching for DNA
regions that exhibit hypersensitivity to
nuclease cleavage (suggestive of an
open chromatin structure) or by a variety
of functional assays, in which a DNA
region distant from a start site was found
to enhance transcription (Carey et al.,
2009). Nuclease hypersensitivity assays
have recently been performed at a
genome-wide level (e.g., Boyle et al.,
2008), but hypersensitivity results with
activated macrophages have not been re-
ported. Potential enhancers can also be
identified by searching for conserved
noncoding sequences, but evidence of
sequence conservation cannot distin-
guish enhancers whose activities are
induced by a stimulus from conserved
DNA regions with other functions.
To identify potential LPS-induced
enhancers, Ghisletti et al. relied on evi-
dence that p300, a transcription coactiva-
tor and protein acetyltransferase, is fre-
quently recruited to active promoters
and enhancers (Heintzman et al., 2007)
(Figure 1). They also focused on evidence
that histone H3 is monomethylated on
lysine 4 (H3K4me1) in the vicinity of
enhancers, whereas this same residue is
trimethylated (H3K4me3) in the vicinity of
promoters (Heintzman et al., 2007).
Through ChIP-seq analysis of p300 in
unstimulated and LPS-stimulated macro-
phages, Ghisletti et al. identified 10,806
DNA regions that exhibit p300 association
in LPS-stimulated macrophages; 2,742 of
these regions exhibited greatly reduced
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Figure 1. Schematic Representation of
a Basic LPS-Induced Enhancer
The data presented by Ghisletti et al. (2010)
demonstrate that, in resting macrophages, LPS-
induced enhancers tend to be bound by the
transcription factor PU.1 and exhibit monomethy-
lation of histone H3K4. Modest depletion of
histones was also observed. During macrophage
development, PU.1 binding, either alone or in
combination with other factors, may promote
monomethylation of H3K4 on surrounding nucleo-
somes by histone methyltransferases (arrows and
question mark). These enhancer features may be
required for susceptibility to enhancer activation
in response to macrophage stimulation. After stim-
ulation, inducible transcription factors, including
NF-kB, IRF family members, and other inducible
factors (TFs), bind their recognition sites in
the enhancer and recruit the transcription coacti-
vator/protein acetyltransferase p300 or CBP.
The enhancer-bound factors are then likely to
communicate with proteins bound to the gene’s
promoter via DNA looping to enhance the fre-
quency of transcription initiation and/or the effi-
ciency of transcription elongation and transcript
processing (Carey et al., 2009; Medzhitov and
Horng, 2009; Smale, 2010).
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unstimulated cells. Interestingly, ChIP-
seq analysis of histone H3K4 methyla-
tion revealed that most of the nonpro-
moter DNA regions exhibiting inducible
p300 association were contained within
domains of constitutively high H3K4me1
and low H3K4me3. This result supports
the hypothesis that the peaks of inducible
p300 correspond to enhancers and
further suggests that inducible enhancers
could not have been identified through an
analysis of inducible H3K4 monomethyla-
tion. An additional benefit of using p300
binding to identify inducible enhancers is
that the p300 association peaks are
much narrower than the H3K4me1 peaks,leading to more precise localization of
the putative enhancers. Finally, the con-
stitutive H3K4me1 signals suggest that,
although these putative enhancers may
be functionally inactive in mature unsti-
mulated macrophages, they are likely to
be associated with transcription factors;
transcription factor binding during the
development of mature macrophages
may confer susceptibility to transcrip-
tional activation after macrophage stimu-
lation, perhaps by promoting the estab-
lishment of a chromatin structure that is
permissive to activation.
To further understand the organization
of the LPS-induced enhancers, Ghisletti
et al. monitored conservation of the
underlying DNA sequence through evolu-
tion and then searched for conserved,
consensus recognition motifs for known
transcription factors. As anticipated, con-
siderable enrichment within the enhancer
set was observed for motifs recognized
by factors that are known to participate
in LPS-induced transcription, such as
NF-kB and IRF family members. Surpris-
ingly, however, the most highly enriched
sequence represented a recognition mo-
tif for the transcription factor PU.1. ChIP-
seq analysis with PU.1 antibodies con-
firmed that PU.1 is bound to a substantial
fraction of the putative enhancers in
both unstimulated and stimulated macro-
phages.
PU.1 has long been known to play a crit-
ical role in macrophage development
(Scott et al., 1994; Friedman, 2007), but
these new results suggest that it may
frequently carry out a separate but related
function inmarking enhancers for a subset
of genes that are induced inmacrophages
by environmental stimuli. Consistent
with this hypothesis, siRNA knockdown
of PU.1 resulted in reduced levels of
H3K4me1 at several enhancers and PU.1
overexpression in fibroblasts promoted
H3K4 monomethylation and changes
in chromatin structure at representative
macrophage-specific enhancers.
The results presented by Ghisletti et al.
(2010) reveal the power of ChIP-seq for
providing important insights into molec-
ular mechanisms that coordinate the
regulation of large groups of genes.
Although PU.1 binding sites were previ-
ously observed in the promoters and
enhancers of several tissue-specific and
inducible genes, the remarkably high
frequency with which PU.1 is associatedImmunity 3with putative LPS-induced enhancers
could only be revealed by a genome-
wide analysis. The hypothesis emerging
from these results, that PU.1 is a cen-
tral player in the marking of inducible
enhancers during macrophage develop-
ment, can now be examined in greater
mechanistic depth through analyses of
representative model genes, with con-
siderable confidence that the results
obtainedwill be relevant to a large fraction
of LPS-induced enhancers.
Although future studies of representa-
tive model genes will provide further
mechanistic insight, the ChIP-seq results
raise additional questions that will be diffi-
cult to answer with current technologies.
Most of these questions are related to
the fact that ChIP-seq cannot reveal the
precise functions of the 2742 DNA regions
that exhibit LPS-induced p300 binding.
For example, because the number of
genes strongly activated within 2 hr of
LPS stimulation appears to be far less
than 2742 (Amit et al., 2009), only a subset
of the regions exhibiting inducible p300
binding may correspond to bona fide
enhancers. Alternatively, each inducible
gene may require multiple LPS-induced
enhancers, or macrophage activation by
LPS may involve global changes in
genome organization or chromatin struc-
ture that are orchestrated by p300-asso-
ciated DNA regions that are not dedicated
to the activation of individual genes.
An additional possibility is that many of
these putative enhancers may help regu-
late constitutively expressed genes that
exhibit only minimal changes in expres-
sion after LPS stimulation; these minimal
changes may appear insignificant to the
molecular biologist, but may be critical in
a biological setting.
Finally, it is important to emphasize that
the current study represents one of the
first successful efforts employing ChIP-
seq to identify and characterize common
properties of a large set of coordinately
regulated enhancers. One can envision
the application of this same strategy
to identify and characterize sets of
enhancers regulated by a wide range of
stimuli, as well as enhancers linked to
developmental pathways and other key
biological processes. Comparative anal-
yses of the enhancer signatures that
are likely to emerge from these studies
over the next few years may lead to
additional insights into global networks2, March 26, 2010 ª2010 Elsevier Inc. 297
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Previewsregulating transcription within a mamma-
lian genome.
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Macroautophagy was thought to be an unspecific bulk degradation process. However, Ponpuak et al. (2010)
show in this issue of Immunity that cytosolic proteins are selectively recruited to autophagosomes to become
metabolized to bactericidal peptides.Macroautophagy, one of at least three
autophagic pathways that deliver cyto-
plasmic constituents for lysosomal degra-
dation, has been originally characterized
by its ability to prolong survival during
times of starvation by recycling of cellular
content for energy and macromolecular
building block generation. However, mul-
tiple studies have demonstrated during
the last 5 years that this catabolic path-
way can also be used for innate and adap-
tive immunity to intracellular pathogens
(Mu¨nz, 2009). Although during starvation
the choice of macroautophagic substrate
might be less specific and rapid energy
generation might be the main objective,
immunity to intracellular pathogens by
macroautophagy should obviously target
these specifically for lysosomal degrada-
tion while leaving other cytoplasmic con-
tent unperturbed.
In support of this concept, Ponpuak
and colleagues demonstrate in this issue
of Immunity that ribosomal proteins are
selectively recruited to autophagosomes
via the anchor protein p62 (sequesto-
some 1) and metabolized to bactericidal
peptides (Ponpuak et al., 2010). In addi-
tion to this function in innate immunity,
selective macroautophagy was first de-scribed for the steady-state degradation
of mitochondria and the import of hydro-
lase proenzymes into lysosomes via this
pathway (Kanki et al., 2009; Okamoto
et al., 2009; Shintani and Klionsky,
2004). The autophagy-related gene (atg)
products 32 and 19 were identified to
mediate this selective import of the re-
spective organelles and protein aggre-
gates into autophagosomes. Similar
mechanisms were suspected to mediate
selective intracellular pathogen clearance
by macroautophagy. Along these lines,
Terje Johansen and his colleagues identi-
fied two proteins, called p62 (sequesto-
some 1) and neighbor of BRCA1 gene
(NBR1), that could link ubiquitinated
substrates to Atg8 (LC3) via their ubiqui-
tin-associated (UBA) domains and LC3
interaction regions (LIR) (Bjørkøy et al.,
2005; Kirkin et al., 2009). Ubiquitinated
protein aggregates had been found to
accumulate in the absence of macro-
autophagy and in autophagosomes. In
addition, Atg8 (LC3) was an attractive
anchor for substrate recruitment into
autophagosomes, because this ubiqui-
tin-like molecule gets coupled to phos-
phatidylethanolamine on both the outer
and inner autophagosomal membraneduring macroautophagy initiation, and
remains associated with the inner mem-
brane after autophagosome completion
even in its lysosomal degradation. How-
ever, overall macroautophagic degrada-
tion of long-lived proteins and autophago-
some formation was not affected by loss
of p62 (sequestosome 1), but ubiquiti-
nated aggregate formation was substan-
tially impaired (Komatsu et al., 2007).
This suggested that either these ubiquitin
with Atg8 (LC3) bridging adaptor proteins
were not important for substrate recruit-
ment to autophagosomes or they were
redundant for overall macroautophagic
flux, each recruiting just a subset of
substrates.
Both theories were additionally sup-
ported by the fact that NBR1 degradation
by macroautophagy was indeed insensi-
tive to p62 (sequestosome 1) loss (Kirkin
et al., 2009). The new study by Ponpuak
and colleagues in this issue of Immunity
(Ponpuak et al., 2010) now provides
evidence for the second hypothesis of
selective recruitment of a subset of sub-
strates by each of these ubiquitin binding
Atg8 (LC3) adaptor proteins. They dem-
onstrate that p62 (sequestosome 1) is
required for the mycobactericidal activity
